About us

Normax Biomed is an extremely experienced team with combined experience of 685 years:

Business, Technology & Engineering (290 Years)
Biomedical Science (220 Years)
Artificial Intelligence (175 Years)

Meet Our Team

Peter A. Jensen, MFA BSc

Chief Executive Officer

40 years experience

Mr. Jensen was educated at UCSB in BioScience (1976-80) and at UCLA in Multimedia Production (1984-88). Mr. Jensen is an entrepreneur and CEO with 40 years of experience in industry (1986-2024). As CEO, Mr. Jensen delivered the first-ever Proof-of-Value For Bond life-cycle on Ethereum Blockchain (Deutsche Bank, 2015) and he personally delivered a 50X ROI for investors with the first-ever mobile app for Ericsson (1999).

Benny Daniëls

Chief Strategy Officer

40 years experience

Mr. Daniels is an international business development consultant with 40 years experience in the biopharma industry. Skilled in early phase business development, investment support and partnering, Mr. Daniëls has supported oncology start-ups from Italy, Portugal, Finland, India, Canada, Benelux, Scandinavia, Baltics, UK and US.

Bart Landuyt, PhD MBA

Chief Science Officer

25 years experience

Dr. Landuyt has over 25 years experience in biotechnology, oncology, infectious diseases, functional genomics, cellular assays, and AI driven drug discovery. Dr. Landuyt served at the University of KU Leuven in the Tech Transfer Office (2009-23). Dr. Landuyt was a Postdoctoral Researcher in Functional Genomics (2006-08).

Lucas Pitcher

Strategic SynBio Advisor

25 years experience

With a strong science background in Molecular Biology and current synthetic biotech advances, Mr. Pitcher has over 25 years experience in business development and international sales and marketing across molecular diagnostics, blood banking, biotechnology, pharmaceutical and health care sectors.

David G. Wilson

Strategic Advisor

25 years experience

Mr. Wilson has over 30 years experience in film production, gaming, storytelling, screenwriting, including 11 feature films (six 007). Developed 23 features at Eon Screenwriters Workshop. Managed James Bond franchise licensing, merchandising & product placement. 5 Triple-AAA video game titles. Current Specialties: franchise management, new media development, start-ups, creative production, AgTech, MedTech, and Security.

Rupert Lewis

Oyster Venture Partners

CEO

Financial Advisor to Normax. Experienced fundraising / sell-side advisor, with a proven track record of supporting business; SME, PE/VC backed, plc’s. Extensive network and access to life science / healthcare VC investor pool. Extensive global M&A experience (50+) and network having led on deal origination, buy-side, sell-side and integration mandates. Worked across the international business arena, especially in Life Science, Scientific, TIC, Pharmaceutical, Environmental, Oil and Gas, Chemical, Fire Safety and Facility Management sectors. Led a number of fund raise transactions in/for PE backed businesses, as well as secondary PE deals.

Educated Antigen Receptor Therapy (EARTh) Clinical Trial Principal Investigators (PI’s)

Guy Jerusalem MD, Head of Medical Oncology at CHU Sart Tilman Liege, The Arsène Burny Cancer Institute (ICAB), Wallonia, Belgium
Charles Pottier MD, Medical Oncology, The Arsène Burny Cancer Institute (ICAB) of the CHU de Liège, Wallonia, Belgium
Mick Button MD, Medical Oncology, University Hospital Llandough, Velindre Cancer Center, Cardiff, Wales, United Kingdom

NRMX C-Suite

For rapid scaling, Mr. Jensen has recruited a C-suite of fifteen including 3 MDs and 6 PhDs (known personally 10-40 years) with over 685 cumulative years of experience including: Chief Medical Officer, a world-leader in Bioinformatics, Chief Medical Safety Officer, a world-leader in Drug Safety, and Chief Technology Officer with 40 years experience leading large teams in Software Development and global AI deployments at Microsoft and Amazon.